1,226 results on '"Flentje, Michael"'
Search Results
302. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including Acetazolamide in human Glioblastoma
303. OP234
304. Hsp90 inhibition by NVP-AUY922 and NVP-BEP800 decreases migration and invasion of irradiated normoxic and hypoxic tumor cell lines
305. Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 foci
306. Radiosensitization of Glioblastoma Cell Lines by the Dual PI3K and mTOR Inhibitor NVP-BEZ235 Depends on Drug-Irradiation Schedule
307. Desynchronization of Cartesian k-space sampling and periodic motion for improved retrospectively self-gated 3D lung MRI using quasi-random numbers.
308. Hypofraktionierte Radiotherapie des lokalisierten Prostatakarzinoms.
309. Organerhaltende Therapie des muskelinvasiven Blasenkarzinoms: 10-Jahres-Daten der britischen BC2001-Studie.
310. 13 - Oxygen-enhanced Proton Magnetic Resonance Imaging of the Human Lung
311. Accuracy of Real-time Couch Tracking During 3-dimensional Conformal Radiation Therapy, Intensity Modulated Radiation Therapy, and Volumetric Modulated Arc Therapy for Prostate Cancer
312. Hsp90 Inhibitors NVP-AUY922 and NVP-BEP800 May Exert a Significant Radiosensitization on Tumor Cells along with a Cell Type-Specific Cytotoxicity
313. Radiotherapy alone for stage I-III low grade follicular lymphoma: long-term outcome and comparison of extended field and total nodal irradiation
314. GILT study: Oral vinorelbine (NVBo) and cisplatin (P) with concomitant radiotherapy (RT) followed by either consolidation (C) with NVBo plus P plus best supportive care (BSC) or BSC alone in stage (st) III non-small cell lung cancer (NSCLC): Final results of a phase (ph) III study.
315. Five years' results of the German ARO 04-01 trial of concurrent 72 Gy hyperfractionated accelerated radiation therapy (HART) plus once weekly cisplatinum/5-FU versus mitomycin C/5-FU in stage IV head and neck cancer.
316. Radiochemotherapy With Cisplatin (P) And Oral Vinorelbine (NVBo) Followed By Consolidation With Vinorelbine/Cisplatin Or Best Supportive Care (BSC) In Stage III Non Small Cell Lung Cancer (NSCLC): Preliminary Results From A Phase III Study
317. PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma
318. Hsp90 inhibitor NVP-AUY922 enhances radiation sensitivity of tumor cell lines under hypoxia
319. Advance directives: prevalence and attitudes of cancer patients receiving radiotherapy
320. Konzentriert gegen den Zeitfaktor
321. T‐one insensitive steady state imaging: A framework for purely T2‐weighted TrueFISP
322. Adaptive Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer Does Not Underdose the Microscopic Disease and has the Potential to Increase Tumor Control
323. Gene expression inhibition of N-Myc downregulated gene 1 (NDRG1) monitoring and facilitation via transfectional transfer of NDRG1-siRNA constructs into- in vitro-cultured human glioblastoma cells
324. Dosimetric evaluation of intrafractional tumor motion by means of a robot driven phantom
325. Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme
326. kV Cone-Beam CT-Based IGRT
327. Image-Guided Radiotherapy
328. Small interfering RNA targeting HIF-1α reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro
329. Cardiac Magnetic Resonance Imaging Findings in 20-year Survivors of Mediastinal Radiotherapy for Hodgkin's Disease
330. Potential of Adaptive Radiotherapy to Escalate the Radiation Dose in Combined Radiochemotherapy for Locally Advanced Non–Small Cell Lung Cancer
331. Fast intensity-modulated arc therapy based on 2-step beam segmentation
332. Late complete remission of supratentorial primitive neuroectodermal tumor (CNS‐PNET) after multiple relapses
333. Modulation of Carbonic Anhydrase 9 (CA9) in Human Brain Cancer
334. Dose–response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy
335. Feasibility Study for Markerless Tracking of Lung Tumors in Stereotactic Body Radiotherapy
336. Toxicity after Intensity-Modulated, Image-Guided Radiotherapy for Prostate Cancer
337. Correlating quantitative MR measurements of standardized tumor lines with histological parameters and tumor control dose
338. Influence of Continuous Table Motion on Patient Breathing Patterns
339. Semi-robotic 6 degree of freedom positioning for intracranial high precision radiotherapy; first phantom and clinical results
340. Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer
341. Concurrent Chemoradiation Therapy With Docetaxel/Cisplatin Followed by Docetaxel Consolidation Therapy in Inoperable Stage IIIA/B Non–Small-Cell Lung Cancer: Results of a Phase I Study
342. Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy - Long-term results
343. Evalution of surface-based deformable image registration for adaptive radiotherapy of non-small cell lung cancer (NSCLC)
344. Is ad-hoc plan adaptation based on 2-Step IMRT feasible?
345. Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes?
346. Clinical Outcome of Dose-Escalated Image-Guided Radiotherapy for Spinal Metastases
347. Remarks on reporting and recording consistent with the ICRU Reference Dose
348. Effect of Breathing Motion in Radiotherapy of Breast Cancer
349. Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy
350. Steep dose gradients for simultaneous integrated boost IMRT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.